Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice.
Collin ChallisAcacia HoriTimothy R SampsonBryan B YooRosemary C ChallisAdam M HamiltonSarkis K MazmanianLaura A Volpicelli-DaleyViviana GradinaruPublished in: Nature neuroscience (2020)
Parkinson's disease is a synucleinopathy that is characterized by motor dysfunction, death of midbrain dopaminergic neurons and accumulation of α-synuclein (α-Syn) aggregates. Evidence suggests that α-Syn aggregation can originate in peripheral tissues and progress to the brain via autonomic fibers. We tested this by inoculating the duodenal wall of mice with α-Syn preformed fibrils. Following inoculation, we observed gastrointestinal deficits and physiological changes to the enteric nervous system. Using the AAV-PHP.S capsid to target the lysosomal enzyme glucocerebrosidase for peripheral gene transfer, we found that α-Syn pathology is reduced due to the increased expression of this protein. Lastly, inoculation of α-Syn fibrils in aged mice, but not younger mice, resulted in progression of α-Syn histopathology to the midbrain and subsequent motor defects. Our results characterize peripheral synucleinopathy in prodromal Parkinson's disease and explore cellular mechanisms for the gut-to-brain progression of α-Syn pathology.
Keyphrases
- high fat diet induced
- resting state
- white matter
- oxidative stress
- traumatic brain injury
- gene expression
- poor prognosis
- spinal cord
- type diabetes
- metabolic syndrome
- functional connectivity
- insulin resistance
- cerebral ischemia
- multiple sclerosis
- binding protein
- heart rate
- wild type
- small molecule
- heart rate variability
- brain injury
- spinal cord injury
- parkinson disease
- skeletal muscle
- chemotherapy induced
- amino acid
- blood brain barrier
- protein protein